Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Japanese Journal of Clinical Oncology|November 4, 2020
Recent advances and future perspectives in adjuvant and neoadjuvant immunotherapies for lung cancerMasaya Yotsukura, Kazuo Nakagawa, Kenji Suzuki, et al.
Japanese Journal of Clinical Oncology|November 15, 2017
Neoadjuvant and adjuvant therapy for Stage III non-small cell lung cancerShun-Ichi Watanabe, Kazuo Nakagawa, Kenji Suzuki, et al.
Japanese Journal of Clinical Oncology|January 28, 2021
Surgical challenges in multimodal treatment of N2-stage IIIA non-small cell lung cancerMasafumi Yamaguchi, Kazuo Nakagawa, Kenji Suzuki, et al.
Lung Cancer (Amsterdam, Netherlands)|February 12, 2025
Longitudinal recurrence risk of adjuvant cytotoxic chemotherapy and gefitnib in resected lung cancer: A combined analysis of phase III studiesHiroaki Akamatsu, Tomomi Nishikawa, Yuriko Takeda, et al.
The Annals of Thoracic Surgery|July 24, 2019
High-Risk Factors for Recurrence of Stage I Lung Adenocarcinoma: Follow-up Data From JCOG0201Yasuhiro Tsutani, Kenji Suzuki, Teruaki Koike, et al.
Lancet (London, England)|April 24, 2022
Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trialHisashi Saji, Morihito Okada, Masahiro Tsuboi, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|April 26, 2002
Clinical utility of ursodeoxycholic acid in preventing flutamide-induced hepatopathy in patients with prostate cancer: a preliminary studyMunekado Kojima, Kazumi Kamoi, Osamu Ukimura, et al.
The Lancet. Respiratory Medicine|March 9, 2023
Segmentectomy for ground-glass-dominant lung cancer with a tumour diameter of 3 cm or less including ground-glass opacity (JCOG1211): a multicentre, single-arm, confirmatory, phase 3 trialKeiju Aokage, Kenji Suzuki, Hisashi Saji, et al.
Hinyokika Kiyo. Acta Urologica Japonica|May 12, 2006
[Epidemiological survey of sexually transmitted male urethritis in Kyoto Prefecture]Koji Yoshimura, Shingo Yamamoto, Akihiro Kawauchi, et al.
Cancer Science|November 13, 2020
Tumor mutation burden as a biomarker for lung cancer patients treated with pemetrexed and cisplatin (the JIPANG-TR)Kazuko Sakai, Masahiro Tsuboi, Hirotsugu Kenmotsu, et al.
Pageof 5